258 results
Page 6 of 13
8-K
EX-99.1
hig8q7g2d1 xmn
11 Aug 23
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
7:02am
8-K
EX-10.2
cozpdx8 weiv2
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.1
dgd0 770hxt9uf6
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-99.1
h8p2jugx emv
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
r472skwe pjjn
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-2.1
9212y
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-99.1
w8rmr45446la lj5s
22 Jun 23
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
5:20pm
8-K
EX-99.1
7r55umcdcebkcjd
11 May 23
Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results
7:01am
8-K
EX-99.1
2sh5yk 447m2
25 Apr 23
Results of Operations and Financial Condition
4:31pm
8-K
EX-99.1
1ptg wpppn0
12 Apr 23
Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine Levels
8:59am
8-K
s9e2s2u
12 Apr 23
Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine Levels
8:59am
PRE 14A
sbqx5v0di 60
7 Apr 23
Preliminary proxy
4:02pm
8-K
t2lb0xot
30 Nov 22
Departure of Directors or Certain Officers
7:05am
8-K
EX-99.2
xl0qo 5dd9hejo5bnvoh
3 Nov 22
Aeglea BioTherapeutics Reports Third Quarter 2022 Financial Results and Provides Program Updates
7:02am